Advertisement

Acceleron Pharma Inc. XLRN

Set alert

Price alert · XLRN

All alert types
178.75 +178.75 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
10.93B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-54.17
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2021
50-d avg
169.49
200-d avg
137.95
1y target
178.88

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for XLRN has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Other Income → Expenses: $180.00KRoyalty → Revenue: $32.04MExpenses → Selling, General & Admin: $45.11MExpenses → Research & Development: $59.72MExpenses → Income Tax: $15.00KGross Profit → Expenses: $34.20MRevenue → Gross Profit: $34.20MCost Sharing → Revenue: $2.16MNet Loss → Expenses: $70.47MOther Income$180.00KGross Profit$34.20MNet Loss$70.47MExpenses$104.84MSelling, General & Admin$45.11MResearch & Development$59.72MIncome Tax$15.00KRevenue$34.20MRoyalty$32.04MCost Sharing$2.16M

Period ending Sep 30, 2021 · select a line to chart its history

Income statement

XLRN quarterly income statement
34.20M
34.20M
34.20M
104.83M
59.72M
45.11M
-70.63M
15.00K
-70.47M
-70.47M
-70.47M
-70.47M
-1.16
-1.16
-1.16
-70.45M
-70.45M
60.94M
60.94M

Balance sheet

XLRN quarterly balance sheet
336.46M
336.46M
316.06M
254.11M
61.95M
34.20M
696.61M
27.75M
787.85M
8.16M
20.11M
57.37M
11.95M
69.69M
-1.07B
-398.00K
718.15M
718.15M
91.24M
20.11M
12.32M
5.09M

Cash flow

XLRN quarterly cash flow
2.82M
14.15M
56.00K
-2.41M
14.15M
56.79M
59.20M
-70.89M
11.42M
Advertisement